Erysipelothrix rhusiopathiae, the cause of swine erysipelas and human erysipeloid, produces a haemolysin. A recombinant plasmid, pHLY, conferring haemolytic activity on Escherichia coli was isolated from a genomic library of Ery. rhusiopathiae strain Tama-96. This plasmid was stable in RecA' E. coli, but unstable in a RecA+ strain. A spontaneous deletion plasmid, pMini-HLY, also conferring haemolytic activity was derived from pHLY. Two ORFs were detected in pHLY. Analysis of pMini-HLY and other deletion clones established that ORF2 was associated with haemolytic activity. The sequence of ORFl was highly homologous to those of transposases in the IS30 family. The deletion which generated pMini-HLY was between two short direct repeat (DR) sequences flanking the ORFl sequence, and there were inverted repeat sequences inside the two DR sequences, suggesting an insertion element. No sequence homology to the deduced amino acid sequence of ORF2 was detected in the databases, but its sequence was characteristic of a surface lipoprotein. Western blot analysis, using antiserum against the 16 kDa protein produced from ORF2, found the protein to be commonly distributed in all Erysipelothrix species.
INTRODUCTION
Erysipelothrix rhusiopathiae causes erysipelas in swine and a variety of diseases in other animals, as well as erysipeloid, a human skin disease (Wood, 1984) . Erysipelas can occur as an acute septicaemia or chronic disease with development of arthritic lesions and endocarditis and continues to be a major cause of economic loss in swine-producing areas of the world. Much of the interest in Ery. rhusiopathiae is due to the chronic and progressive character of the arthritic lesions in pigs, which superficially resemble those of human rheumatoid arthritis. However, the pathogenesis of these lesions remains unclear.
Erysipelothrix species form a weak haemolytic zone (a- haemolysis) on blood agar plates. In many pathogenic t Present address: National Institute of Animal Health, Tsukuba Science City, lbaraki 305-0856, Japan.
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bacteria haemolysins are involved in virulence (Stanley et al., 1998) . The haemolysin (listeriolysin) in Listeria monocytogenes, which is phylogenetically closely related to Ery. rhusiopathiae, is essential for intracellular survival (Bielecki et al., 1990) . The aim of this work was to identify the gene encoding the haemolysin of Ery. rhusiopathiae and to compare this haemolysin to haemolysins in other pathogenic bacteria.
METHODS
Bacterial strains and media. Table 1 lists the Erysipelothrix strains used in this study. Ery. rhusiopathiae Tama-96 was used as the basis for construction of a genomic library.
Escherichia cob MC1061 was used as a host strain to maintain recombinant plasmids. E. coli HBlOl was used as a RecAstrain. Brain Heart Infusion broth (BHI ; Difco) supplemented with 0.1 '/o (w/v) Tween 80 (BHIT) and L broth were used to cultivate the Erysipelothrix and E. coli strains, respectively.
When necessary, media were supplemented with 1.5 YO (w/v) agar or the appropriate antibiotic. T o examine the haemolytic activity of bacterial cells, we used Columbia agar (BRL) supplemented with 5 '/o sheep blood (blood agar). :' Fragments detected in Southern blots of BarnHI-digested genomic DNA using the Hind111 fragment of pHLY as a probe.
Plasmid construction. Fig. 1 shows the plasmids used in this study. The vector plasmid pHY300PLK was used to construct a library of genomic DNA of Ery. rhusiopathiae strain Tama-96 partially digested with Sau3AI. E. coli transformants from the library were spread on blood agar plates supplemented with ampicillin (150 pg ml-l) to detect colonies from the library showing haemolytic activity. Deletion derivatives shown in Fig. 1 were derived by restriction endonuclease digestion of pHLY.
Expression of haemolytic protein and its detection. A BamHI linker was inserted into the SpeI site of pHLY (Fig. l) , and then a BarnHI-Hind111 DNA fragment was cloned into the BamHI and Hind111 sites of pQE30 (Qiagen) to yield pQE-HLY. The polyhistidine-tagged fusion protein was purified according to the manufacturer's instructions using the QIAexpress system and used to immunize rabbits to make rabbit polyclonal antibody against the fusion protein (anti-Hly) ,
Using anti-Hly, Western blotting was performed with Erysipelothrix and E. coli strains. Antigens were prepared from bacterial cell pellets and culture supernatants. Briefly, 1 ml of the bacterial cell culture was centrifuged, the supernatant was The supernatant was mixed with 50 pl 100 ' / o trichloroacetic acid, and after centrifugation precipitated protein was resuspended in 20 pl lysis buffer. Protein suspensions were heated at 100 "C for 5 min, and then 10 p1 of each suspension was loaded on a 20% SDS-PAGE gel.
Haemolysis experiments. The polyhistidine-tagged fusion protein and PBS-washed E . coli MC1061 cells carrying pHLY were suspended in 200 pl PBS at concentrations of 1.0 mg ml-l and 1 x lo8 cells ml-', respectively. Then the solutions were incubated with a 1 (v/v) suspension of sheep red blood cells at 37 "C for 1 h. Unlysed cells were removed by centrifugation at 740g. The amount of lysis was determined by measuring (1982) . Database searches with amino acid sequences used the FASTA program in the DDBJ. Vaccination using the ORF2 product and challenge with the Tama-96 strain were performed as described by Makino et al. (1998) .
RESULTS AND DISCUSSION

Isolation of a plasmid inducing haemolysis and its genetic analysis
E. coli clones from the Tama-96 gene library were spread on blood agar plates to select colonies showing haemolysis ( Hlyf). Two clones were independently isolated, a n d o n e of them, pHLY, w a s used for this study (Fig. 2 ) . Deletion mutants were constructed using the restriction enzyme cleavage sites in pHLY t o find the region essential for haemolytic activity. In addition, when E. coli MC1061 containing pHLY w a s spread o n a blood agar plate supplemented with ampicillin, the plasmid pMini-HLY was generated spontaneously by deletion of a b o u t 1 kb from pHLY. The spontaneous deletion mutant still induced haemolysis (Fig. 1) . The region essential for the haemolytic activity of pHLY was located within a 0.5 kb fragment containing the PvuII a n d HindIII sites (Fig. 1) .
To characterize the gene essential for haemolysis a n d the deletion which generated pMini-HLY, the nucleotide sequences of the cloned regions in pHLY a n d pMini-HLY were determined. Two ORFs were identified in S. MAKINO, K. KATSUTA a n d T. SHIRAHATA pHLY (Fig. 1 ). ORFl encoded 313 amino acids to give a predicted 37 kDa product and ORF2 encoded 149 amino acids, predicting a 16.2 kDa product. A deletion of 1078 bp had generated pMini-HLY from pHLY (Fig. 1) .
The results demonstrated that ORF2 was associated with haemolysis ( Fig. 1) .
T o understand the mechanism generating the deletion in pMini-HLY, the stability of pHLY in E. coli MC1061 RecA' and HBlOl RecA-was examined by subculturing for about 20 generations in L broth supplemented with ampicillin (50 pg ml-l). When plasmids carried in 10 Hly' colonies of each host strain were examined, pHLY was found to be stable in the RecA-host, but eight of ten Hly' colonies from the RecA' host had plasmids with molecular masses similar to pMini-HLY, as determined by agarose gel electrophoresis (data not shown).
Two direct repeat (DR) sequences of 11 bp (ACACC-CGAATC) were found bracketing the deleted region in pHLY, and pMini-HLY carried only one DR (Fig. 1) .
The deleted region in the eight deletion plasmids obtained by subculturing the RecA' host strain was identical to that in pMini-HLY from DNA sequence analysis (data not shown). These results suggest that deletion of ORFl to give pMini-HLY occurred by RecA--dependent homologous recombination between DRs (Fig. 1) .
ORFl is homologous to IS30 transposases
A database search for sequences similar to ORFl found that the sequence of the C-terminal region from P,,, had 30.7-35.7 O/O identity to the sequences of the C-terminal region of the transposases of IS4351 (Smith, 1987) , IS30 (Dalrymple et al., 1984) , IS1161 (Giffard et al., 1993) , IS1070 (Vaughan & de Vos, 1995) and IS1239 (Lortie et al., 1994) , which are insertion elements of the IS30
family. In addition, at both ends of a 1067 bp region bracketed by two DRs in pHLY, two inverted repeat sequences of 20 bp, which were 50% identical to each other, were detected (Fig. 1) . These findings suggest ORFl may function as a transposase, and the region deleted from pHLY may be the first insertion element identified in Ery. rhusiopathiae. We have not yet confirmed that the element is able to transpose. Since the sequences of the inverted repeats were only 50% identical to each other, it is likely that the frequency of its transposition may be extremely low even if the O R F l product has a transposase activity (Mahillon & Chandler, 1998 ).
Characteristics of the haemolysin
Although we were unable to identify sequences with significant similarity to ORF2 in the database, the protein it encoded was predicted by the PROST program (Nakai & Kanehisa, 1991) to be secreted and acylated, with a signal peptidase I1 cleavage site between G,, and C,, (Fig. 3) . Although pAH-S, in which the first 42 bp of ORF2 were deleted, did not induce haemolytic activity, pQE-HLY, with the same deletion but the remainder of the ORF2 coding sequence fused in-frame to the signal sequence of pQE30, induced haemolysis in E. coli (Fig.  1) . The 20-amino-acid N-terminal sequence of the protein encoded by ORF2 was very similar to the Nterminal ends of OspA (Dykhuizen et al., 1993; , TrsH (Morton et a/., 1993) , LytC (Kunst et al., 1997; Lazarevic et al., 1992) and YdhF (Kunst et al., 1997) , all of which contain the lipoprotein consensus sequence (von Heijne, 1989) (Fig. 3 ). In addition, computer prediction (Chou & Fasman, 1978) of the amino acid secondary structure suggested that a ,&turn may occur after the C,, putative acylation site in an 11-amino-acid peptide which contains S18, N,, and NZ2,
indicating that the ORF2 product may be an efficient processed prolipoprotein (Hayashi & Wu, 1990 
